Logo of annrheumdAnnals of the Rheumatic DiseasesVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
Ann Rheum Dis. Apr 2003; 62(4): 308–315.
PMCID: PMC1754484

Cost effectiveness and cost utility analysis of multidisciplinary care in patients with rheumatoid arthritis: a randomised comparison of clinical nurse specialist care, inpatient team care, and day patient team care


Objective: To assess the relative cost effectiveness of clinical nurse specialist care, inpatient team care, and day patient team care.

Methods: Incremental cost effectiveness analysis and cost utility analysis, alongside a prospective randomised controlled trial with two year follow up. Included were patients with rheumatoid arthritis (RA) with increasing difficulty in performing activities of daily living over the previous six weeks. Quality of life and utility were assessed by the Rheumatoid Arthritis Quality of Life questionnaire, the Short Form-6D, a transformed rating scale, and the time tradeoff. A cost-price analysis was conducted to estimate the costs of inpatient and day patient hospitalisations. Other healthcare and non-healthcare costs were estimated from cost questionnaires.

Results: 210 patients with RA (75% female, median age 59 years) were included. Aggregated over the two year follow up period, no significant differences were found on the quality of life and utility instruments. The costs of the initial treatment were estimated at €200 for clinical nurse specialist care, €5000 for inpatient team care, and €4100 for day patient team care. Other healthcare costs and non-healthcare costs were not significantly different. The total societal costs did not differ significantly between inpatients and day patients, but were significantly lower for the clinical nurse specialist patients by at least €5400.

Conclusions: Compared with inpatient and day patient team care, clinical nurse specialist care was shown to provide equivalent quality of life and utility, at lower costs. Therefore, for patients with health conditions that allow for any of the three types of care, the preferred treatment from a health-economic perspective is the care provided by the clinical nurse specialist.

Full Text

The Full Text of this article is available as a PDF (218K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Davis RM, Wagner EG, Groves T. Advances in managing chronic disease. Research, performance measurement, and quality improvement are key. BMJ. 2000 Feb 26;320(7234):525–526. [PMC free article] [PubMed]
  • Hill J, Bird HA, Harmer R, Wright V, Lawton C. An evaluation of the effectiveness, safety and acceptability of a nurse practitioner in a rheumatology outpatient clinic. Br J Rheumatol. 1994 Mar;33(3):283–288. [PubMed]
  • Hobbs R, Murray ET. Specialist liaison nurses. BMJ. 1999 Mar 13;318(7185):683–684. [PMC free article] [PubMed]
  • Temmink D, Hutten JB, Francke AL, Rasker JJ, Abu-Saad HH, van der Zee J. Rheumatology outpatient nurse clinics: a valuable addition? Arthritis Rheum. 2001 Jun;45(3):280–286. [PubMed]
  • Helewa A, Bombardier C, Goldsmith CH, Menchions B, Smythe HA. Cost-effectiveness of inpatient and intensive outpatient treatment of rheumatoid arthritis. A randomized, controlled trial. Arthritis Rheum. 1989 Dec;32(12):1505–1514. [PubMed]
  • Lambert CM, Hurst NP, Forbes JF, Lochhead A, Macleod M, Nuki G. Is day care equivalent to inpatient care for active rheumatoid arthritis? Randomised controlled clinical and economic evaluation. BMJ. 1998 Mar 28;316(7136):965–969. [PMC free article] [PubMed]
  • Tijhuis Gerhardus J, Zwinderman Aeilko H, Hazes Johanna M W, Van Den Hout Wilbert B, Breedveld Ferdinand C, Vliet Vlieland Theodora P M. A randomized comparison of care provided by a clinical nurse specialist, an inpatient team, and a day patient team in rheumatoid arthritis. Arthritis Rheum. 2002 Oct 15;47(5):525–531. [PubMed]
  • Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 Mar;31(3):315–324. [PubMed]
  • de Jong Z, van der Heijde D, McKenna SP, Whalley D. The reliability and construct validity of the RAQoL: a rheumatoid arthritis-specific quality of life instrument. Br J Rheumatol. 1997 Aug;36(8):878–883. [PubMed]
  • Tijhuis GJ, de Jong Z, Zwinderman AH, Zuijderduin WM, Jansen LM, Hazes JM, Vliet Vlieland TP. The validity of the Rheumatoid Arthritis Quality of Life (RAQoL) questionnaire. Rheumatology (Oxford) 2001 Oct;40(10):1112–1119. [PubMed]
  • Hays RD, Sherbourne CD, Mazel RM. The RAND 36-Item Health Survey 1.0. Health Econ. 1993 Oct;2(3):217–227. [PubMed]
  • Brazier John, Roberts Jennifer, Deverill Mark. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002 Mar;21(2):271–292. [PubMed]
  • Stiggelbout AM, Eijkemans MJ, Kiebert GM, Kievit J, Leer JW, De Haes HJ. The 'utility' of the visual analog scale in medical decision making and technology assessment. Is it an alternative to the time trade-off? Int J Technol Assess Health Care. 1996 Spring;12(2):291–298. [PubMed]
  • Tijhuis GJ, Jansen SJ, Stiggelbout AM, Zwinderman AH, Hazes JM, Vliet Vlieland TP. Value of the time trade off method for measuring utilities in patients with rheumatoid arthritis. Ann Rheum Dis. 2000 Nov;59(11):892–897. [PMC free article] [PubMed]
  • Thompson SG, Barber JA. How should cost data in pragmatic randomised trials be analysed? BMJ. 2000 Apr 29;320(7243):1197–1200. [PMC free article] [PubMed]
  • Kazis LE, Anderson JJ, Meenan RF. Effect sizes for interpreting changes in health status. Med Care. 1989 Mar;27(3 Suppl):S178–S189. [PubMed]
  • Wells G, Boers M, Shea B, Tugwell P, Westhovens R, Saurez-Almazor M, Buchbinder R. Sensitivity to change of generic quality of life instruments in patients with rheumatoid arthritis: preliminary findings in the generic health OMERACT study. OMERACT/ILAR Task Force on Generic Quality of Life. Life Outcome Measures in Rheumatology. International League of Associations for Rheumatology. J Rheumatol. 1999 Jan;26(1):217–221. [PubMed]
  • Laupacis A, Bourne R, Rorabeck C, Feeny D, Wong C, Tugwell P, Leslie K, Bullas R. The effect of elective total hip replacement on health-related quality of life. J Bone Joint Surg Am. 1993 Nov;75(11):1619–1626. [PubMed]
  • Katz JN, Phillips CB, Fossel AH, Liang MH. Stability and responsiveness of utility measures. Med Care. 1994 Feb;32(2):183–188. [PubMed]
  • Goossens ME, Vlaeyen JW, Rutten-van Mölken MP, van der Linden SM. Patient utilities in chronic musculoskeletal pain: how useful is the standard gamble method? Pain. 1999 Mar;80(1-2):365–375. [PubMed]
  • Vliet Vlieland TP, Zwinderman AH, Vandenbroucke JP, Breedveld FC, Hazes JM. A randomized clinical trial of in-patient multidisciplinary treatment versus routine out-patient care in active rheumatoid arthritis. Br J Rheumatol. 1996 May;35(5):475–482. [PubMed]
  • Vliet Vlieland TP, Breedveld FC, Hazes JM. The two-year follow-up of a randomized comparison of in-patient multidisciplinary team care and routine out-patient care for active rheumatoid arthritis. Br J Rheumatol. 1997 Jan;36(1):82–85. [PubMed]
  • van Jaarsveld CH, Jacobs JW, Schrijvers AJ, Heurkens AH, Haanen HC, Bijlsma JW. Direct cost of rheumatoid arthritis during the first six years: a cost-of-illness study. Br J Rheumatol. 1998 Aug;37(8):837–847. [PubMed]

Figures and Tables

Figure 1
RAQoL, SF-6D, TRS, and TTO measurements.
Figure 2
Societal costs per patient per semester.

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Group


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • Cited in Books
    Cited in Books
    PubMed Central articles cited in books
  • MedGen
    Related information in MedGen
  • PubMed
    PubMed citations for these articles

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...